Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.235 EUR | -1.11% | +3.47% | -14.69% |
Apr. 15 | Sanofi: progress in hematology trial | CF |
Apr. 15 | Innate Pharma: progress in hematology trial | CF |
Sales 2024 * | 46.78M 50.05M | Sales 2025 * | 74.41M 79.6M | Capitalization | 181M 193M |
---|---|---|---|---|---|
Net income 2024 * | -25M -26.74M | Net income 2025 * | -21M -22.46M | EV / Sales 2024 * | 2.46 x |
Net cash position 2024 * | 65.68M 70.26M | Net cash position 2025 * | 122M 130M | EV / Sales 2025 * | 0.79 x |
P/E ratio 2024 * |
-15.6
x | P/E ratio 2025 * |
3.74
x | Employees | 179 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.91% |
Latest transcript on Innate Pharma
1 day | -1.11% | ||
1 week | +1.59% | ||
Current month | +2.29% | ||
1 month | +3.23% | ||
3 months | -10.96% | ||
6 months | -9.51% | ||
Current year | -14.69% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Vivier
FOU | Founder | 60 | 99-09-22 |
Chief Executive Officer | 62 | 99-09-22 | |
Frederic Lombard
DFI | Director of Finance/CFO | 49 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 99-09-22 | |
Gilles Brisson
BRD | Director/Board Member | 72 | 07-06-25 |
Olivier Martinez
BRD | Director/Board Member | 54 | 10-05-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 2.235 | -1.11% | 60,896 |
24-04-23 | 2.26 | +4.39% | 79,753 |
24-04-22 | 2.165 | +2.61% | 34,564 |
24-04-19 | 2.11 | -1.86% | 61,255 |
24-04-18 | 2.15 | -0.46% | 72,009 |
Real-time Euronext Paris, April 24, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.69% | 195M | |
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- IPH Stock